United Kingdom · 
Who invested in Argonaut Therapeutics?
Argonaut Therapeutics's investors include Oxford Science Enterprises.
2019202020212022
$2.6MVenture$241KRound
United Kingdom · Venture startup
Who invested in Argonaut Therapeutics
Funding summaryUpdated 26 Oct 2026
$2.8Mraised across 2 rounds since 2018, from 2 sources
$2.6MVenture$241KRound
- Latest round
- Round, $241KDec 2022
- Biggest round
- $2.6MVenture · Oct 2018
- Investors
- 1
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Venture, $2.6M Oct 2018
- Biggest round
- $2.6M Venture · Oct 2018
- Between rounds
- 4.3 years from the last two
The rounds
- Dec 2022Round$241K
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
- Oct 2018
Funding filed with regulators
Argonaut Therapeutics filed one raise, $241K in all. Filings say how much was sold and to how many investors; they never name the investors.
- Dec 2022$241KUK share allotment
Founders and team
From Argonaut Therapeutics's own website: 9 on the team.
- A James BanaagChief Financial Officer
- NantBio Inc.Chief Financial Officer
- Professor David KerrChief Medical Officer
- Collette CollOperations Director
- Dr Simon CarrDirector of Pre-clinical Development
- Leonard S SenderNon-Executive Director
- Shonagh MunroResearch Director
- Strategic CollaborationsNon-Executive Director
- Wojciech BarczakTranslational Research Director
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Argonaut Therapeutics
How much has Argonaut Therapeutics raised?
Argonaut Therapeutics has raised $2.8M across 2 rounds since 2018.
When did Argonaut Therapeutics last raise?
Argonaut Therapeutics's most recent round, $241K, was in Dec 2022.
What was Argonaut Therapeutics's biggest round?
Argonaut Therapeutics's largest round on record is $2.6M (Venture), in Oct 2018.
Who backed Argonaut Therapeutics first?
Argonaut Therapeutics's first round on record, in Oct 2018, was backed by Oxford Science Enterprises.
What stage is Argonaut Therapeutics at?
Argonaut Therapeutics's latest named round is a Venture, in Oct 2018.
Where is Argonaut Therapeutics based?
Argonaut Therapeutics is based in the United Kingdom.
Companies like Argonaut Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.